Global Gastric Cancer Drugs Market 2019 Report

The report will be delivered in 2-3 business days.

Gastric Cancer Drugs Global Market Report 2020

Purchase Options

Request Sample

Request For Discount

FAQ

Starting Price : $ 4000.00 | Pages : 200 | Published : January 2020 | SKU CODE : 7231 | Format :

The gastric cancer drugs market consists of sales of drugs for gastric cancer. Gastric cancer, also known as stomach cancer, is the formation of abnormal cells on the lining of stomach resulting in stomach pain and indigestion.

The global gastric cancer drugs market was valued at about $1.4 billion in 2018 and is expected to grow to $2.13 billion at a CAGR of 11.1% through 2022.

Asia Pacific was the largest region in the gastric cancer drugs market in 2018 and is forecasted to register the highest CAGR during 2018-2023.

Increasing number of obesity cases and smoking population increased number of people suffering from gastric cancer. Consuming tobacco and following diet unhealthy diet increases the risk of stomach cancer. According to American Institute For Cancer Research ,1 million new cases of stomach cancer have been reported in 2018. Similarly, according to the estimates of American Cancer Society in 2019, about 27,510 cases of stomach cancer will be diagnosed and 11,140 people will die from stomach cancer. Increase in number of cases in gastric cancer will drive the market for gastric cancer drugs.

Stringent regulations and policies for approval of the drugs restrain the market for gastric cancer drugs. Different regions have their own set of rules, guidelines and regulations set by their respective drugs regulation board. For example, the USFDA regulations for American pharmaceuticals states various conditions with regards to safety and effectiveness of the drug as well as certain labeling requirements. Similarly, the European medicines agency (EMA) gives licenses to the approved drugs before they can be marketed or commercialized in the European continent. Teysuno, a drug for advanced gastric cancer can be only obtained through a valid prescription and the protocol is that every company must assess the effects of using Teysuno and must list out the precautions to be taken by patients and healthcare providers to minimize any possible side effects. These regulations hinder the growth of the gastric cancer drugs market.

Many companies are using combination therapies to cure gastric cancer. Combination therapies help in treating patients with two or more drugs for a single disease and help in better treating the patients. For instance, in 2019, the USFDA has approved Taiho Oncology Inc’s combined product LONSURF trifluridine/tipiracil for pretreated metastatic gastric cancer. This approval is significant for patients living with advanced gastric or GEJ (gastroesophageal junction) adenocarcinoma who have limited effective treatment options after failure of standard treatment options. Advances in the drugs for treatment of gastric cancer will have a positive influence on the gastric cancer drugs’ market.

The gastric cancer drugs market is regulated by government agencies such as European Medicines Agency (EMA), USFDA (the US food and drug ministration), and others. For instance, FDA's Current Good Manufacturing Practice (CGMP) regulation lays down minimum requirements for the methods and facilities used in manufacturing, processing, and packing of a drug product and ensures the quality of drugs produced by manufacturers. Moreover, FDA's guidance provides recommendations to applicants for cancer clinical trials and shows support in new drug applications (NDAs), biologics license applications (BLAs), or supplemental applications.

On April 2019, AstraZeneca, a multinational pharmaceutical and biopharmaceutical company acquired Daiichi Sankyo for $1.35 billion. This acquisition will help AstraZeneca to jointly develop drug Trastuzumab Deruxtecan with Daiichi Sankyo. This drug would help to treat people suffering from breast and gastric cancer. Daiichi Sankyo headquarted at Japan is a global pharmaceutical company which offers innovative products and a robust pipeline for cancer treatment.

Major players in the market are Eli Lilly and company, Novartis, Merck KGaA, Otsuka Pharmaceutical, F. Hoffmann-La Roche

1. Executive Summary

2. Gastric Cancer Drugs Market Characteristics

3. Gastric Cancer Drugs Market Size And Growth

3.1. Global Gastric Cancer Drugs Historic Market, 2014 - 2018, $ Billion

3.1.1. Drivers Of The Market

3.1.2. Restraints On The Market

3.2. Global Gastric Cancer Drugs Forecast Market, 2018 - 2022F, 2025F, 2030F, $ Billion

3.2.1. Drivers Of The Market

3.2.2. Restraints On the Market

4. Gastric Cancer Drugs Market Segmentation

4.1. Global Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Doxorubicin Hydrochloride

Sunitinib

Docetaxel

Mitomycin

Fluorouracil

Imatinib

Trastuzumab

4.2. Global Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Hospitals

Clinics

Others

4.3. Global Gastric Cancer Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Oral

Parenteral

5. Gastric Cancer Drugs Market Regional And Country Analysis

5.1. Global Gastric Cancer Drugs Market, Split By Region, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

5.2. Global Gastric Cancer Drugs Market, Split By Country, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

6. Asia-Pacific Gastric Cancer Drugs Market

6.1. Asia-Pacific Gastric Cancer Drugs Market Overview

6.2. Asia-Pacific Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

6.3. Asia-Pacific Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

7. China Gastric Cancer Drugs Market

7.1. China Gastric Cancer Drugs Market Overview

7.2. China Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F,$ Billion

7.3. China Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F,$ Billion

8. India Gastric Cancer Drugs Market

8.1. India Gastric Cancer Drugs Market Overview

8.2. India Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

8.3. India Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

9. Japan Gastric Cancer Drugs Market

9.1. Japan Gastric Cancer Drugs Market Overview

9.2. Japan Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

9.3. Japan Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

10. Australia Gastric Cancer Drugs Market

10.1. Australia Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

10.2. Australia Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

11. Indonesia Gastric Cancer Drugs Market

11.1. Indonesia Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

11.2. Indonesia Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

12. South Korea Gastric Cancer Drugs Market

12.1. South Korea Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

12.2. South Korea Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

13. Western Europe Gastric Cancer Drugs Market

13.1. Western Europe Gastric Cancer Drugs Market Overview

13.2. Western Europe Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

13.3. Western Europe Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

14. UK Gastric Cancer Drugs Market

14.1. UK Gastric Cancer Drugs Market Overview

14.2. UK Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

14.3. UK Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

15. Germany Gastric Cancer Drugs Market

15.1. Germany Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

15.2. Germany Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

16. France Gastric Cancer Drugs Market

16.4. France Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

16.5. France Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

17. Eastern Europe Gastric Cancer Drugs Market

17.1. Eastern Europe Gastric Cancer Drugs Market Overview

17.2. Eastern Europe Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

17.3. Eastern Europe Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

18. Russia Gastric Cancer Drugs Market

18.1. Russia Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

18.2. Russia Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

19. North America Gastric Cancer Drugs Market

19.1. North America Gastric Cancer Drugs Market Overview

19.2. North America Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

19.3. North America Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

20. USA Gastric Cancer Drugs Market

20.1. USA Gastric Cancer Drugs Market Overview

20.2. USA Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

20.3. USA Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

21. South America Gastric Cancer Drugs Market

21.1. South America Gastric Cancer Drugs Market Overview

21.2. South America Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

21.3. South America Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

22. Brazil Gastric Cancer Drugs Market

22.1. Brazil Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

22.2. Brazil Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

23. Middle East Gastric Cancer Drugs Market

23.1. Middle East Gastric Cancer Drugs Market Overview

23.2. Middle East Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

23.3. Middle East Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

24. Africa Gastric Cancer Drugs Market

24.1. Africa Gastric Cancer Drugs Market Overview

24.2. Africa Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

24.3. Africa Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

25. Gastric Cancer Drugs Market Competitive Landscape And Company Profiles

25.1. Gastric Cancer Drugs Market Competitive Landscape

25.2. Gastric Cancer Drugs Market Company Profiles

25.2.1. Eli Lilly and company

25.2.1.1. Overview

25.2.1.2. Products and Services

25.2.1.3. Strategy

25.2.1.4. Financial Performance

25.2.2. Novartis

25.2.2.1. Overview

25.2.2.2. Products and Services

25.2.2.3. Strategy

25.2.2.4. Financial Performance

25.2.3. Merck KGaA

25.2.3.1. Overview

25.2.3.2. Products and Services

25.2.3.3. Strategy

25.2.3.4. Financial Performance

25.2.4. Otsuka Pharmaceutical

25.2.4.1. Overview

25.2.4.2. Products and Services

25.2.4.3. Strategy

25.2.4.4. Financial Performance

25.2.5. F. Hoffmann-La Roche

25.2.5.1. Overview

25.2.5.2. Products and Services

25.2.5.3. Strategy

25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The Gastric Cancer Drugs Market

27. Gastric Cancer Drugs Market Trends And Strategies

28. Product Pipeline Analysis

29. Gastric Cancer Drugs Market Future Outlook and Potential Analysis

30. Appendix

30.1. Abbreviations

30.2. Currencies

30.3. Research Inquiries

30.4. The Business Research Company

30.5. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2014-2018, $ Billion

Table 2: Global Forecast Market Growth, 2014-2022F, 2025F, 2030F, $ Billion

Table 3: Global Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 4: Global Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 5: Global Gastric Cancer Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 6: Global Gastric Cancer Drugs Market, Split By Region, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 7: Global Gastric Cancer Drugs Market, Split By Country, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 8: Asia-Pacific, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 9: Asia-Pacific, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 10: China, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 11: China, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 12: India, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 13: India, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 14: Japan, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 15: Japan, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 16: Australia, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 17: Australia, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 18: Indonesia, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 19: Indonesia, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 20: South Korea, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 21: South Korea, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 22: Western Europe, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 23: Western Europe, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 24: UK, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 25: UK, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 26: Germany, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 27: Germany, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 28: France, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 29: France, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 30: Eastern Europe, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 31: Eastern Europe, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 32: Russia, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 33: Russia, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 34: North America, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 35: North America, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 36: USA, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 37: USA, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 38: South America, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 39: South America, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 40: Brazil, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 41: Brazil, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 42: Middle East, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 43: Middle East, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 44: Africa, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 45: Africa, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Table 46: Eli Lilly and company Financial Performance

Table 47: Novartis Financial Performance

Table 48: Merck KGaA Financial Performance

Table 49: Otsuka Pharmaceutical Financial Performance

Table 50: F. Hoffmann-La Roche Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2014-2018, $ Billion

Figure 2: Global Forecast Market Growth, 2014-2022F, 2025F, 2030F, $ Billion

Figure 3: Global Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 4: Global Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 5: Global Gastric Cancer Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 6: Global Gastric Cancer Drugs Market, Split By Region, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 7: Global Gastric Cancer Drugs Market, Split By Country, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 8: Asia-Pacific, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 9: Asia-Pacific, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 10: China, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 11: China, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 12: India, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 13: India, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 14: Japan, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 15: Japan, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 16: Australia, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 17: Australia, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 18: Indonesia, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 19: Indonesia, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 20: South Korea, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 21: South Korea, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 22: Western Europe, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 23: Western Europe, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 24: UK, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 25: UK, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 26: Germany, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 27: Germany, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 28: France, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 29: France, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 30: Eastern Europe, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 31: Eastern Europe, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 32: Russia, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 33: Russia, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 34: North America, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 35: North America, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 36: USA, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 37: USA, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 38: South America, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 39: South America, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 40: Brazil, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 41: Brazil, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 42: Middle East, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 43: Middle East, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 44: Africa, Gastric Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 45: Africa, Gastric Cancer Drugs Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

Figure 46: Eli Lilly and company Financial Performance

Figure 47: Novartis Financial Performance

Figure 48: Merck KGaA Financial Performance

Figure 49: Otsuka Pharmaceutical Financial Performance

Figure 50: F. Hoffmann-La Roche Financial Performance

Innovations In The Diabetes Therapies Market

Allergan plc- One Of The Largest Companies In The Global Drugs For Benign Prostatic Hypertrophy Market

Innovation And Development Of Combination Drugs To Enhance Growth Of The Ovarian Cancer Drugs Market

The Global Prostate Cancer Drugs Market Will Reach Around $10 By 2022

Antivirals Are The Largest And Fastest Growing Segment Of The Anti-Infective Drugs Market

Developments in Drug Discovery Procedures Will Aid Market Growth For Diabetes Therapies

Research And Development Initiatives Taken In The Anti-Infective Drugs Market

Research Initiatives And Funding And Demand For New Medicines For Drug-Resistant Infections In The Anti-Infective Drugs Industry

Biologics Market By Types (Monoclonal Antibodies, Therapeutic Proteins And Vaccines), By Trends, By Regions and By Key Players - Global Forecast To 2021

View Report

Pharmaceutical Drugs Market By Segments (Musculoskeletal Disorders Drugs, Cardiovascular Drugs, Oncology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Central Nervous System Drugs, Genito-Urinary Drugs, Respiratory Diseases Drugs, Gastrointestinal Drugs, Hematology Drugs, Dermatology Drugs, Ophthalmology Drugs) - Global Forecast To 2021

Gastric Cancer Drugs Global Market Report 2020

Innovations In The Diabetes Therapies Market

Allergan plc- One Of The Largest Companies In The Global Drugs For Benign Prostatic Hypertrophy Market

Innovation And Development Of Combination Drugs To Enhance Growth Of The Ovarian Cancer Drugs Market

The Global Prostate Cancer Drugs Market Will Reach Around $10 By 2022

Antivirals Are The Largest And Fastest Growing Segment Of The Anti-Infective Drugs Market

Developments in Drug Discovery Procedures Will Aid Market Growth For Diabetes Therapies

Research And Development Initiatives Taken In The Anti-Infective Drugs Market

Research Initiatives And Funding And Demand For New Medicines For Drug-Resistant Infections In The Anti-Infective Drugs Industry

Biologics Market By Types (Monoclonal Antibodies, Therapeutic Proteins And Vaccines), By Trends, By Regions and By Key Players - Global Forecast To 2021

Cardiovascular Drugs Global Market Report 2020

Dermatology Drugs Global Market Report 2020

Gastrointestinal Drugs Global Market Report 2020

Hematology Drugs Global Market Report 2020

Metabolic Disorders Drugs Global Market Report 2020

Musculoskeletal Disorders Drugs Global Market Report 2020

Call Us

+1 3156230293

+44 2071930708

+91 8897263534